Search
Damo Academy Teams Up with Multiple Hospitals to Unveil an AI Model, Overcoming the Precise Identification Challenge for Fatty Liver and Cirrhosis Risks
3 hour ago /
Read about 0 minute
Author：小编
On March 9, 2026, Alibaba's Damo Academy, in partnership with renowned institutions including Shengjing Hospital of China Medical University and Nanjing Drum Tower Hospital (affiliated with Nanjing University), triumphantly developed MAOSS—an innovative AI model tailored for fatty liver screening. Leveraging routine examinations like plain CT scans and serum indicators, this model excels in accurately determining liver fat staging and evaluating the progression of liver fibrosis. Remarkably, it substantially boosts the detection rate of high-risk patients, elevating it from 16.6% to an impressive 52.4%. The groundbreaking research has been published in the esteemed journal Nature Communications.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
